Biology of Lipid Metabolism Laboratory. People Lab head Matthew Watt Research Assistant Maria Matzaris.

Slides:

Advertisements

Similar presentations

Fat Intake and Athletic Performance

Advertisements

ADIPONECTIN Its emerging role in Atherosclerosis, Metabolic Syndrome and Insulin Resistance RT ERASMUS Chemical Pathology, Tygerberg Hospital, NHLS &University.

Acetyl-CoA Carboxylase-A New Target in the Fight against Obesity Naida Idrizovic.

Insulin Signaling – Insulin Resistance Elmus G. Beale, Professor Texas Tech University Health Sciences Center Paul L. Foster School of Medicine PhD, Baylor.

ADIPOSE TISSUE Presentation # 2 Kelli Carlson and Kelly Zook.

Control of Energy The Original Biofuels. Importance of Glucose Regulation Too little – Brain problems Too much –Osmotic water loss (cellular and systemic)

Chapter 5 Type 2 diabetes. Chapter overview Introduction Aetiology Prevalence Obesity as a risk factor Physical inactivity as a risk factor Low physical.

Diabetes Mellitus (Lecture 2). Type 2 DM 90% of diabetics (in USA) Develops gradually may be without obvious symptoms may be detected by routine screening.

Early immune disorders induced by childhood obesity E Carolan, AH Hogan, D O’Shea.

Physiological Role and Molecular Mechanism of Adiponectin Yumi Ando Pomona College Advanced Biochemistry.

Joellen Little-Kemper November 9, Introduction Imagine that the activation of a single gene could result in increased: *obesity resistance *insulin.

Non-alcoholic Fatty Liver Disease

Regulating Blood Sugar Islets of Langerhans groups of cells in the pancreas beta cells produce insulin alpha cells produce glucagon.

Regulation of insulin levels Starter: what do each of the following cells produce and are they part of the endocrine or exocrine system; –α cells –β cells.

cardio protection: Focus on

Laboratory for Cellular and Metabolic Engineering Engineering biology to produce biomolecules, fuels, and pharmaceuticals Hal Alper Department of Chemical.

The Road To Metabolic syndrome

Good Fat vs Bad Fat and Cancer Prevention

Endocrine Adrenal gland And Pancreas. Adrenal gland Structure Cortex ◦ Glucocorticoids  Chemical nature  Effects  Control of secretion ◦ Mineralocorticoids.

Diabetes Mellitus Type 2

Ashley Patton DO/PhD student McCall/Schwartz Lab.

Effect of 8 Weeks of Overfeeding on Ectopic Fat Deposition and Insulin Sensitivity: Testing the “Adipose Tissue Expandability” Hypothesis Featured Article:

Hepatic Steatosis Chen-Yu Wang

Diabetes Mellitus Classification & Pathophysiology.

"We can be very successful at controlling diabetes."

POWERPOINT PRESENTATION Group Members- Labiba Sharmin Hossain ( ) Marvia Nabi Ratree ( )

 Insulin is a peptide hormone released by beta cells when glucose concentrations exceed normal levels (70–110 mg/dL).  The effects of insulin on its.

Jerrold J. Heindel PhD Acting Chief Cellular Organ and Systems Pathobiology Branch National Institute of Environmental Health Sciences National Institutes.

Click to edit Master subtitle style 10/1/2016 Genetic Contribution to Obesity Caitlin Baker Lisa Bakken Gail Feldkamp.

PPAR δ : a dragger in the heart of the metabolic syndrome J.Clin.Invest.116:590~597(2006) R3 Song Se-bin Grant D. Barish, Vihang A.Narkar, and Ronald M.Evans.

Chapter 5 Type 2 diabetes.

Unit 1 Lesson 6 Activity 3- Insulin and the Human Body

3.2.1 Outline the terms metabolism, anabolism and aerobic catabolism

Chapter 7 Metabolic syndrome

Peter L. Lee, Yuefeng Tang, Huawei Li, David A. Guertin

By Dr. Dipendra Raj Pandeya, PhD Assistant Professor Department of Clinical Laboratory Science College of Applied Medical Sciences Al Jouf University.

Intermyocellular fat depot

by José J. Fuster, Noriyuki Ouchi, Noyan Gokce, and Kenneth Walsh

Volume 14, Issue 2, Pages (August 2011)

Figure 2 Pathophysiology of hyperglycaemia in T2DM

המשותף לכל סוגי הסוכרת היפרגליקמיה כרונית.

Is Energy Deficiency Good in Moderation?

Vascular biology of metabolic syndrome

Obesity Heats Up Adipose Tissue Lymphocytes

In and Out: Adipose Tissue Lipid Turnover in Obesity and Dyslipidemia

THE ENDOCANNABINOID SYSTEM AND CARDIOMETABOLIC RISK

Interaction of hypercholesterolemia and inflammation in atherogenesis

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Volume 7, Issue 6, Pages (June 2008)

Playtime Prevents Obesity by Brain-Mediated Fat Browning

Hua V. Lin, Domenico Accili Cell Metabolism

Irisin, Turning Up the Heat

Muscle as a “Mediator” of Systemic Metabolism

Chengcheng Jin, Jorge Henao-Mejia, Richard A. Flavell Cell Metabolism

In and Out: Adipose Tissue Lipid Turnover in Obesity and Dyslipidemia

Figure 3 Regulation of insulin sensitivity by innate immune cells

Inflammation and Lipid Signaling in the Etiology of Insulin Resistance

Volume 10, Issue 1, Pages (July 2009)

Volume 24, Issue 20, Pages R988-R993 (October 2014)

Volume 142, Issue 4, Pages e6 (April 2012)

Differentiation and Stem Cells

Volume 14, Issue 2, Pages (August 2011)

Cellularity of epididymal adipose tissue.

Ann Marie Schmidt, Kathryn J. Moore Cell Metabolism

Shih-Yen Weng, Detlef Schuppan Journal of Hepatology

Of Mice and Men: Not ExAKTly the Same?

NF-κB, Inflammation, and Metabolic Disease

3.2.1 Outline the terms metabolism, anabolism and aerobic catabolism

Presentation transcript:

Biology of Lipid Metabolism Laboratory

People Lab head Matthew Watt Research Assistant Maria Matzaris

Obesity is a serious medical conditions that has doubled in prevalence over the last 20 years and affects 1 in every 3 Australian adults. Our research is directed towards understanding the molecular and cellular regulation of fat metabolism, in adipose tissue and skeletal muscle, and how defective fat metabolism lead to the development of insulin resistance (precursor to type 2 diabetes). Research focus

Exercise and Metabolic Phenotyping Cell culture, genetic perturbations and molecular biology

Current projects Our laboratory utilizes mammalian systems and genetic manipulation of cultured cells and mice models. We have a strong focus on phenotypic evaluation. The honours research projects for 2009 are: 1.Understanding how the fatty liver ‘talks’ to other cells. 2.Examining the role of proinflammatory cytokines in the development of a diabetes. 3.The adipocyte as an active participant in the development of metabolic disease. 4.Does increasing fat breakdown increase the capacity of muscle mitochondria to burn more fat?